Cóndor, J. M., Rodrigues, C. E., de Sousa Moreira, R., Canale, D., Volpini, R. A., Shimizu, M. H., . . . Andrade, L. (2016). Treatment With Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction. Stem Cells Transl Med.
Citação norma ChicagoCóndor, José M., Camila E. Rodrigues, Roberto de Sousa Moreira, Daniele Canale, Rildo A. Volpini, Maria H.M Shimizu, Niels O.S Camara, Irene de L. Noronha, and Lúcia Andrade. "Treatment With Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction." Stem Cells Transl Med 2016.
MLA citiranjeCóndor, José M., et al. "Treatment With Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction." Stem Cells Transl Med 2016.